UMass Lowell will resume on-campus instruction, research and campus life for Fall 2020. View the plan for more info.
The Biomedical Terahertz Technology Center (BTTC) was established in 2012 with the goal of translating the extensive terahertz technology expertise available at UMass Lowell to biomedical applications. Terahertz radiation, which lies between the microwave and infrared regions of the electromagnetic spectrum, is highly sensitive to water content in tissues and, unlike X-rays, it is non-ionizing and has been shown to be capable of detecting intrinsic contrast between normal and cancerous tissues. This makes terahertz radiation well suited for biomedical imaging, especially for studying colorectal cancer and non-melanoma skin cancer. Learn More.